Cipher Pharmaceuticals Inc (CPHRF)
6.61
-0.04
(-0.60%)
USD |
OTCM |
May 09, 15:10
Cipher Pharmaceuticals 1 Year Total Returns (Daily): 177.1% for May 8, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 08, 2024 | 177.1% |
| May 07, 2024 | 173.3% |
| May 06, 2024 | 175.7% |
| May 03, 2024 | 167.2% |
| May 02, 2024 | 164.4% |
| May 01, 2024 | 153.0% |
| April 30, 2024 | 155.1% |
| April 29, 2024 | 152.6% |
| April 26, 2024 | 154.3% |
| April 25, 2024 | 155.5% |
| April 24, 2024 | 154.3% |
| April 23, 2024 | 158.7% |
| April 22, 2024 | 147.5% |
| April 19, 2024 | 145.1% |
| April 18, 2024 | 151.1% |
| April 17, 2024 | 153.4% |
| April 16, 2024 | 156.1% |
| April 15, 2024 | 168.4% |
| April 12, 2024 | 171.9% |
| April 11, 2024 | 166.7% |
| April 10, 2024 | 151.4% |
| April 09, 2024 | 147.2% |
| April 08, 2024 | 146.0% |
| April 05, 2024 | 153.1% |
| April 04, 2024 | 157.9% |
| Date | Value |
|---|---|
| April 03, 2024 | 164.0% |
| April 02, 2024 | 149.4% |
| April 01, 2024 | 142.1% |
| March 28, 2024 | 169.0% |
| March 27, 2024 | 181.0% |
| March 26, 2024 | 193.4% |
| March 25, 2024 | 184.0% |
| March 22, 2024 | 164.7% |
| March 21, 2024 | 164.7% |
| March 20, 2024 | 154.5% |
| March 19, 2024 | 129.0% |
| March 18, 2024 | 137.9% |
| March 15, 2024 | 117.8% |
| March 14, 2024 | 92.34% |
| March 13, 2024 | 89.42% |
| March 12, 2024 | 89.42% |
| March 11, 2024 | 90.49% |
| March 08, 2024 | 87.52% |
| March 07, 2024 | 100.1% |
| March 06, 2024 | 96.67% |
| March 05, 2024 | 93.33% |
| March 04, 2024 | 95.93% |
| March 01, 2024 | 93.43% |
| February 29, 2024 | 90.15% |
| February 28, 2024 | 93.94% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-73.43%
Minimum
Mar 20 2020
226.9%
Maximum
Mar 30 2021
34.39%
Average
34.47%
Median
Nov 02 2023
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | 4.71% |
| Aurinia Pharmaceuticals Inc | -53.98% |
| Edesa Biotech Inc | -35.00% |
| Lexaria Bioscience Corp | 245.4% |
| Xenon Pharmaceuticals Inc | 1.01% |